Kymera Therapeutics Trades Flat Near 81 as Biotechnology Sector Awaits Catalysts Plus500 Reaffirms FullYear Guidance After Quarterly Revenue Climbs 11 NVCR Q1 2026 Earnings EPS Misses Estimates as Wider Loss Overshadows Modest Stock Advance Custard Apple Market Faces Growth Potential Amid Export Challenges